Isotretinoin Induced Psychotic Mania: A Case Report
Author(s) -
Faruk Kurhan,
Gülsüm Zuhal Kamış
Publication year - 2020
Publication title -
turkish journal of psychiatry
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.218
H-Index - 28
ISSN - 1300-2163
DOI - 10.5080/u25066
Subject(s) - mania , family history , psychiatry , olanzapine , suicidal ideation , bipolar disorder , isotretinoin , mood , psychology , medicine , depression (economics) , mood disorders , psychosocial , clinical psychology , psychiatric history , schizophrenia (object oriented programming) , poison control , suicide prevention , acne , epilepsy , dermatology , anxiety , environmental health , economics , macroeconomics
Biological, genetic and psychosocial factors may play a role in the aetiology of bipolar mood disorder (BPD). BPD episodes might be triggered by isotretinoin, a retinoid derivative of vitamin A with a role in cellular proliferation and differentiation. Due to its association with depression, suicidal ideation and suicide attempts, American Food and Drug Administration (FDA) issued a placement of a label warning for isotretionin. Personal or family history of psychiatric disorders was emphasized in the literature for the risk of mood episodes following isotretionin treatment. Here we aim to present the case of an 18- year old young male adult, without personal or family history of a psychiatric disorder, who developed psychotic mania within the first week of isoretinoin which was prescribed for acne vulgaris. Psychotic mania symptoms receded within one week after starting olanzapine (10 mg/day). We believe this case is significant in demonstrating the occurence of a manic episode after isoretinoin in individuals lacking a personal or family history of psychiatric diagnoses.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom